Health
Study links metformin to slowed cognitive decline – Australian Hospital + Healthcare Bulletin
A study of older Australians with type 2 diabetes revealed that taking metformin resulted in slower cognitive decline with lower dementia rates than those who d…
Used by millions of people across the globe to optimise blood glucose levels, metformin is regarded as the first-line treatment for most cases of type 2 diabetes.
A six-year study of older Australians with type 2 diabetes has revealed that those taking metformin experienced slower cognitive decline with lower dementia rates than those who did not use the medication.
Led by researchers at the Garvan Institute of Medical Research and the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, the …
-
Noosa News12 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General5 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General16 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025